Decline in rates of acquired multidrug-resistant tuberculosis after implementation of the directly observed therapy, short course (DOTS) and DOTS-Plus programmes in Taiwan

Journal of Antimicrobial Chemotherapy

Volumn 68, Issue 8, 2013, Pages 1910-1916

  Chien, Jung Yien ^a,b   Lai, Chih Cheng ^c   Tan, Che Kim ^c   Chien, Shun Tien ^a   Yu, Chong Jen ^b   Hsueh, Po Ren ^b  

^a Chest Hospital   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c CHI MEI MEDICAL CENTER   (Taiwan)

Author keywords

Acquired resistance; MDR TB; Totally drug resistant tuberculosis; XDR TB

Indexed keywords

AMINOSALICYLIC ACID; CAPREOMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; CLOFAZIMINE; CYCLOSERINE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; KANAMYCIN; LEVOFLOXACIN; MOXIFLOXACIN; OFLOXACIN; PROTIONAMIDE; QUINOLONE DERIVATIVE; RIFAMPICIN; STREPTOMYCIN; THYMIDINE;

ADULT; AGE; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; FEMALE; HEALTH PROGRAM; HUMAN; INFECTION RISK; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; SHORT COURSE THERAPY; TAIWAN;

ACQUIRED RESISTANCE; MDR-TB; TOTALLY DRUG-RESISTANT TUBERCULOSIS; XDR-TB;

ADULT; AGED; AGED, 80 AND OVER; ANTITUBERCULAR AGENTS; DIRECTLY OBSERVED THERAPY; DISEASE TRANSMISSION, INFECTIOUS; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; RETROSPECTIVE STUDIES; TAIWAN; TUBERCULOSIS, MULTIDRUG-RESISTANT; YOUNG ADULT;

EID: 84880711017     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt103     Document Type: Article

References (26)

1. World Health Organization. Global Tuberculosis Control: WHO report 2011. http://www.who.int/tb/publications/global_report/2011/gtbr11_ full.pdf(11 January 2013, date last assessed).
2. Zignol M, Hosseini MS, Wright A et al. Global incidence of multidrug-resistant tuberculosis. J Infect Dis 2006; 194: 479-85.
3. Centers for Disease Control and Prevention. Notice to readers: revised definition of extensively drug-resistant tuberculosis. MMWR Morb Mortal Wkly Rep 2006; 55: 1176.
4. Lai CC, Tan CK, Huang YT et al. Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a Medical Center in Taiwan. Clin Infect Dis 2008; 47: e57-63.
5. Velayati AA, Masjedi MR, Farnia P et al. Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in Iran. Chest 2009; 136: 420-5.
6. Lai CC, Tan CK, Lin SH et al. Clinical and genotypic characteristics of extensively drug-resistant and multidrug-resistant tuberculosis. Eur J Clin Microbiol Infect Dis 2010; 29: 597-600.
7. Yu MC, Wu MH, Jou R. Extensively drug-resistant tuberculosis, Taiwan. Emerg Infect Dis 2008; 14: 849-50.
8. Mitnick CD, Shin SS, Seung KJ et al. Comprehensive treatment of extensively drug-resistant tuberculosis. N Engl J Med 2008; 359: 563-74.
9. Clinical and Laboratory Standards Institute. Susceptibility Testing of Mycobacteria, Nocardiae, and other aerobic Actinomycetes-Second Edition: Approved Standard M24-A2. CLSI, Wayne, PA, USA, 2011.
10. Ershova JV, Kurbatova EV, Moonan PK et al. Acquired resistance to second-line drugs among persons with tuberculosis in the United States. Clin Infect Dis 2012; 55: 1600-7.
11. World Health Organization, Stop TB Initiative. Treatment of Tuberculosis: Guidelines. 4th edn. Geneva: World Health Organization, 2010.
12. Shin SS, Keshavjee S, Gelmanova IY et al. Development of extensively drug-resistant tuberculosis during multidrug-resistant tuberculosis treatment. Am J Respir Crit Care Med 2010; 182: 426-32.
13. Han LL, Sloutsky A, Canales R et al. Acquisition of drug resistance in multidrug-resistant Mycobacterium tuberculosis during directly observed empiric retreatment with standardized regimens. Int J Tuberc Lung Dis 2005; 9: 818-21.
14. Yu CC, Chang CY, Liu CE et al. Drug resistance pattern of Mycobacterium tuberculosis complex at a medical center in central Taiwan, 2003-2007. J Microbiol Immunol Infect 2010; 43: 285-90.
15. Liu WL, Lai CC, Tan CK et al. Declining drug resistance of Mycobacterium tuberculosis isolates from elderly patients in Taiwan, 2000-2008. Eur J Clin Microbiol Infect Dis 2010; 29: 1413-6.
16. Chacon L, Lainez M, Rosales E et al. Evolution in the resistance of Mycobacterium tuberculosis to anti-tuberculosis drugs in Nicaragua. Int J Tuberc Lung Dis 2009; 13: 62-7.
17. Lu PL, Lee YW, Peng CF et al. The decline of high drug resistance rate of pulmonary Mycobacterium tuberculosis isolates from a southern Taiwan medical centre, 1996-2000. Int J Antimicrob Agents 2003; 21: 239-43.
18. Liu Y, Jiang G, Zhao L et al. [Drug resistance of Mycobacterium tuberculosis in a nationwide epidemiological survey in China in the year of 2000]. Zhonghua Jie He He Hu Xi Za Zhi 2002; 25: 224-7.
19. Chen YT, Lee JJ, Chiang CY et al. Effective interventions and decline of antituberculosis drug resistance in Eastern Taiwan, 2004-2008. PLoS One 2012; 7: e31531.
20. The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Anti-Tuberculosis Drug Resistance in the World. Report No. 4. http://www.who.int/tb/publications/2008/drs_report4_26feb08.pdf(11 January 2013, date last assessed).
21. Bonilla CA, Crossa A, Jave HO et al. Management of extensively drug-resistant tuberculosisin Peru: cureis possible. PLoS One 2008;3: e2957.
22. Ramarokoto H, Randriamiharisoa H, Rakotoarisaonina A et al. Bacteriological follow-up of tuberculosis treatment: a comparative study of smear microscopy and culture results at the second month of treatment. Int J Tuberc Lung Dis 2002; 6: 909-12.
23. Mkopi A, Range N, Lwilla F et al. Adherence to tuberculosis therapy among patients receiving home-based directly observed treatment: evidence from the United Republic of Tanzania. PLoS One 2012; 7: e51828.
24. Gillespie SH, Kennedy N. Fluoroquinolones: a new treatment for tuberculosis?. Int J Tuberc Lung Dis 1998; 2: 265-71.
25. Berning SE. The role of fluoroquinolones in tuberculosis today. Drugs 2001; 61: 9-18.
26. Jacobs MR. Activity of quinolones against mycobacteria. Drugs 1995; 49 Suppl 2: 67-75.